Significant Ownership of Neal C. Bradsher

Location: New York, NY
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Neal C. Bradsher.

Notify me when Neal C. Bradsher files a new Schedule 13D/G report.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
IMDX	Insight Molecular Diagnostics Inc.	Common Stock, no par value	37%	$90,615,668	+$3,913,042	12,082,089	+4.5%	Neal C. Bradsher	10 Feb 2026
LCTX	Lineage Cell Therapeutics, Inc.	Common shares	23%	$97,763,723		57,848,357	0%	NEAL C. BRADSHER	12 Nov 2025

Schedules 13D/G Reported by Neal C. Bradsher:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.